ѻý

Jump to Main Content

Newsroom

ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.

News and Press Releases

Pneumococcal Vaccines Linked with Fewer Severe Infections Among Children with Sickle Cell Disease
Sep. 12, 2023

ASH Names Editors-in-Chief of New Blood Journals
Sep. 8, 2023

Patients with AML Who Received Vitamin C/D Supplements Had Fewer Complications, But No Overall Survival Benefit Seen
Sep. 6, 2023

ASH Announces New ASH-AMFDP Hematology Scholars
Aug. 23, 2023

First-of-its-Kind Study Reveals Predictive Factors for Outcomes of AdvancedStage AL Amyloidosis
Aug. 15, 2023

Obesity and High Weight Linked to Adverse Outcomes in Leukemia Treatment
Jul. 11, 2023

ASH Advocates for Diversity in Medicine
Jun. 30, 2023

ASH Announces the 2023 Honorific Award Recipients
Jun. 28, 2023

Study Uncovers Direct Link Between Blood Group A and a Higher Risk for COVID-19 Infection
Jun. 27, 2023

New Data Informs Treatment of Blood Cancer During Pregnancy
Jun. 1, 2023

Statement on New ASH Clinical Practice Guidelines on Thrombophilia
May 17, 2023

Criteria for Selecting Who Can Enroll in Multiple Myeloma Clinical Trials May Exclude Patients from Racial and Ethnic Minorities
May 4, 2023

Extreme Poverty a Key Driver for Relapse in Kids With ALL
Apr. 18, 2023

A Promising Outlook: CAR T Cells Improve Patient Quality of Life
Mar. 30, 2023

ASH President Commends Reintroduction of Sickle Cell Disease Medicaid Demonstration Program
Mar. 22, 2023

Quantifying the Life Expectancy Gap for People Living with Sickle Cell Disease
Mar. 16, 2023

View All

Protect Medical Research

Urge your members of Congress to support continued medical research funding.

Take Action